Hepatitis C virus genotype 5 in Mexico: A case report with successful treatment and a literature review

被引：0

作者：

Rubio-Lezama, M. A. ^{[1
]}

Lopez-Alferez, R. ^{[1
]}

Santillan-Arreygue, L. ^{[2
]}

Romero-Figueroa, M. ^{[2
]}

机构：

[1] Hosp Gen Zona 58 Gen Manuel Avila Camacho, Inst Mexicano Seguro Social, Coordinac Clin Educ & Invest Salud, Tlalnepantla Da Baz, Estado Mexico, Mexico

[2] Inst Mexicano Seguro Social, Delegac Estado Mexico Poniente, Coordinac Delegac Educ & Invest Salud, Mexico City, DF, Mexico

来源：

REVISTA DE GASTROENTEROLOGIA DE MEXICO | 2013年 / 78卷 / 03期

关键词：

Management; Epidemiology; Sustained virologic response; Blood-borne disease;

D O I：

10.1016/j.rgmx.2012.12.001

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Hepatitis C virus (HCV) genotype 5 is extremely rare and there is very little reported on its management in the medical literature. We present herein the case of a patient with HCV genotype 5 that presumably acquired the disease through a blood transfusion during infancy. Sustained virologic response was achieved after 24 weeks of treatment. According to the available information on HCV genotype 5 treatment, it has a similar response to that of HCV genotype 1. Our patient presented with various favorable outcome factors. There is much less reported on the treatment of HCV genotype 5 than there is regarding HCV genotypes 1, 2, 3, and 4. This is mainly due to the low prevalence of genotype 5 in the Mexican environment. (C) 2012 Asociacion Mexicana de Gastroenterologia. Published by Masson Doyma Mexico S.A. Alt rights reserved.

引用

页码：191 / 195

页数：5

共 25 条

[1] The unexpected discovery of a focus of hepatitis C virus genotype 5 in a Syrian province [J].

Antaki, N. ;

Haddad, M. ;

Kebbewar, K. ;

Abdelwahab, J. ;

Hamed, O. ;

Aaraj, R. ;

Alhaj, N. ;

Haffar, S. ;

Assil, M. ;

Ftayeh, M. ;

Assaad, F. ;

Doghman, D. ;

Ali, T. ;

Nasserelddine, M. ;

Ali, A. ;

Antaki, F. .

EPIDEMIOLOGY AND INFECTION, 2009, 137 (01) :79-84

[2] Efficacy of interferon plus ribavirin in the treatment of hepatitis C virus genotype 5 [J].

Antaki, N. ;

Hermes, A. ;

Hadad, M. ;

Ftayeh, M. ;

Antaki, F. ;

Abdo, N. ;

Kebbewar, K. .

JOURNAL OF VIRAL HEPATITIS, 2008, 15 (05) :383-386

[3]

Antaki N, 2004, J INFECT DIS, V189, P1397

[4] Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow [J].

Asselah, Tarik ;

Marcellin, Patrick .

LIVER INTERNATIONAL, 2012, 32 :88-102

[5] Identification of numerous hepatitis C virus genotypes in Montreal, Canada [J].

Bernier, L ;

Willems, B ;

Delage, G ;

Murphy, DG .

JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (11) :2815-2818

[6] Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5.: A French multicentre retrospective study [J].

Bonny, C. ;

Fontaine, H. ;

Poynard, T. ;

Hezodes, C. ;

Larrey, D. ;

Marcellin, P. ;

Bourliere, M. ;

Bronowicki, J. P. ;

Merle, P. ;

Zarski, J. P. ;

Sapey, T. ;

Guillemard, C. ;

Ughetto, S. ;

Henquell, C. ;

Nicolas, C. ;

Roche, C. ;

Randl, K. ;

Bommelaer, G. ;

Abergel, A. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (04) :593-600

[7] Efficacy of Interferon-Based Antiviral Therapy in Patients With Chronic Hepatitis C Infected With Genotype 5: A Meta-Analysis of Two Large Prospective Clinical Trials [J].

D'Heygere, Francois ;

George, Christophe ;

Van Vlierberghe, Hans ;

Decaestecker, Jochen ;

Nakad, Antoine ;

Adler, Michael ;

Delwaide, Jean ;

Laureys, Annick ;

Nevens, Frederik .

JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (05) :815-819

[8]

Davalos Moscol Milagros, 2010, Ann Hepatol, V9 Suppl, P49

[9] Hepatitis C virus genotype 5 in southern Belgium: Epidemiological characteristics and response to therapy [J].

Delwaide, J ;

Gerard, C ;

Reenaers, C ;

Vaira, D ;

Bastens, B ;

Bataille, C ;

Servais, B ;

Maes, B ;

Belaiche, J .

DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (12) :2348-2351

[10] High prevalence of hepatitis C virus type 5 in central France evidenced by a prospective study from 1996 to 2002 [J].

Henquell, C ;

Cartau, C ;

Abergel, A ;

Laurichesse, H ;

Regagnon, C ;

De Champs, C ;

Bailly, JL ;

Peigue-Lafeuille, H .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (07) :3030-3035

← 1 2 3 →